Market Research Future (MRFR) has published a cooked research report on the “Global Vitamin K2 Market” that contains the information from 2022 to 2030.

Market Highlights

The global vitamin K2 market is expected to register a CAGR of 31.08% during the forecast period and hit USD 744.3 billion by 2030.

The cases of vitamin K2 deficiency are increasing due to changing lifestyle and food-related habits. Vitamin K2 is naturally produced in human guts by bacteria. Vitamin K2 is rare in the western diet, and it is necessary to involve vitamin K2 through supplementary diet and pharmaceutical products. The key factors influencing market growth are increasing patient pool suffering from vitamin deficiency, rising demand for nutraceutical products containing vitamin K2, and increasing cases of osteoporosis and arthritis. However, the stringent regulations for nutraceuticals may hamper the market growth in the forecast period. On the contrary, the multifunctional ingredients offer opportunities for market players to develop advanced products.

Key Players

MRFR recognizes the following companies as the key players in the global vitamin K2 market— Kappa Bioscience (Norway), Lesaffre (France), Viridis BioPharma (India), Seebio Biotech (Shanghai) Co.,Ltd (China), DSM (Netherlands), International Flavors & Fragrances Inc. (US), Kyowa Hakko Bio Co. Ltd (Japan), Purayati (India), Vox Nutrition (US) and Anderson Global Group, LLC. (US).

Segment Analysis

The global vitamin K2 market has been divided based on product type, source, form and application.

Based on product type, the market has been segregated into MK-7, MK-4 and Combination Drugs. On basis of source, the market is bifurcated into natural and synthetic. On the basis of form, the market is divided into capsules & tablets, powder, oil, and others such as tablets, capsules, and soft gels. On basis of application, the market is bifurcated into nutraceutical & food and pharmacuetical.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Vitamin K2 Market Research Report

Vitamin K2 Market Regional Report Analysis

The global vitamin K2 market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate the market due to rising adoption of herbal medicines, increasing focus of consumers on health and wellness, surging healthcare costs, and boosting demand from pharmaceutical, food and beverage, and cosmetic industries. Europe is also likely to hold a significant share in the global vitamin test market. This can be attributed to growing consumer awareness about vitamin K2 coupled with the increasing demand for vitamin K2 in the UK, France, and Germany. Moreover, the increasing number of exhibitions and events in the region further supports the growth of the market.

Asia-Pacific is expected to register rapid growth over the forecast period due to the presence of huge opportunities for the market, growing aging population, rising concerns about health among population, and increasing patient pool suffering from vitamin deficiency. Global major companies are signing contracts with prominent market players or setting their own agents in some major countries and regions taking charge of the regional business to build their international market positions. The Middle East & Africa is expected to witness moderate market growth during the forecast period owing to growing health concerns, surging consumption of compound feed, and rising urbanization coupled with increasing disposable income in the UAE, Saudi Arabia, and Bahrain.

Key Findings of the Study

• The global vitamin K2 market was evaluated at USD 43 million in 2020 and is projected to register a CAGR of 38.48% during the assessment period.


• The Americas accounted for the largest share in the global market due to the the rising adoption of herbal medicines, increasing focus of consumers on health and wellness, surging healthcare costs, and boosting demand from pharmaceutical, food and beverage, and cosmetic industries.


• Based on product type, MK-7 segment held the largest market share with a value of USD 55.03 million in 2020.


• On the basis of source, the natural segment dominated the market with a value of USD 48.45 million in 2020.


• By form, the capsules & tablets segment accounted for the largest market share with a value of USD 37.59 million in 2020.


• Based on application, the nutraceutical & food segment accounted for the largest market share with a value of USD 64.56 million in 2020.


• Kappa Bioscience (Norway), Lesaffre (France), Viridis BioPharma (India), Seebio Biotech (Shanghai) Co.,Ltd (China) and DSM (Netherlands) are the key market players.